Hypothalamic–pituitary–ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia

BACKGROUND: We assessed adult hypothalamic–pituitary–ovarian function following treatment with chemotherapy and cranial irradiation for childhood acute lymphoblastic leukaemia. METHODS: The patients (n = 12) had median age at diagnosis of 4.7 years, and at assessment of 20.8 years. They collected a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human reproduction (Oxford) 2001-09, Vol.16 (9), p.1838-1844
Hauptverfasser: Bath, Louise E., Anderson, Richard A., Critchley, Hilary O.D., Kelnar, Christopher J.H., Wallace, W.Hamish B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1844
container_issue 9
container_start_page 1838
container_title Human reproduction (Oxford)
container_volume 16
creator Bath, Louise E.
Anderson, Richard A.
Critchley, Hilary O.D.
Kelnar, Christopher J.H.
Wallace, W.Hamish B.
description BACKGROUND: We assessed adult hypothalamic–pituitary–ovarian function following treatment with chemotherapy and cranial irradiation for childhood acute lymphoblastic leukaemia. METHODS: The patients (n = 12) had median age at diagnosis of 4.7 years, and at assessment of 20.8 years. They collected a daily urine sample over two to five consecutive menstrual cycles (total of 41 cycles) for analysis of LH and steroid excretion. Blood sampling and ovarian ultrasound examination was performed in the early follicular phase. Sixteen healthy women with regular menstrual cycles were recruited as controls. RESULTS: Urinary LH excretion was significantly lower in patients throughout the cycle, particularly during the LH surge (P < 0.0001). The length of the luteal phase was significantly shorter in patients than in normal controls (12.2 ± 0.3 versus 13.6 ± 0.4 days, P = 0.01) with a high prevalence of short (≤11 days) luteal phases (15/39 cycles). Luteal phase pregnanediol excretion was slightly but not significantly lower. Follicular and luteal phase excretion of oestrone was lower in patients than in controls (P = 0.01). Early follicular phase plasma oestradiol was also lower in the patient group (P = 0.032) although LH, FSH, inhibin A and B concentrations were similar. CONCLUSIONS: These data indicate that treatment for childhood leukaemia results in subtle ovulatory disorder in some patients, probably related to cranial irradiation. Follow-up of these women is required to detect any effect on reproductive potential.
doi_str_mv 10.1093/humrep/16.9.1838
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71130502</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humrep/16.9.1838</oup_id><sourcerecordid>71130502</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-20588ecd7f6a882115b4edda2f713a63b89c4566e63eccba7b8a5f6336a14b663</originalsourceid><addsrcrecordid>eNqNkE2LFDEQhoMo7rh69yR90Yv0bNLprs4c3UUdcUAEBdlLqE5XM3H7y3yIffM_-A_9JWbtwb16SkGe963iYeyp4FvBd_LiGAdH84WA7W4rlFT32EaUwPNCVvw-2_ACVC4EiDP2yPuvnKdRwUN2JkRV1EpVG7bsl3kKR-xxsOb3z1-zDdEGdEuap-_oLI5Zu_gujibYacywC-SyOW2NDbmAfWaONKQGcjgvGY5tZhyONn1Y57C1-DfWTS5DEwNlPcUbpMHiY_agw97Tk9N7zj6_ef3pap8fPrx9d_XqkJuyFCEveKUUmbbuAJUq0uVNSW2LRVcLiSAbtTNlBUAgyZgG60Zh1YGUgKJsAOQ5e7H2zm76FskHPVhvqO9xpCl6XQshecWLBPIVNG7y3lGnZ2eHpEILrm9161W3FqB3-lZ3ijw7dcdmoPYucPKbgOcnAL3BvktqjPV3XMlBcKgT93Llpjj_z9p8pa0P9OMfj-5Gp6660vsv1xoOl4frQr7XH-UfXCutAw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71130502</pqid></control><display><type>article</type><title>Hypothalamic–pituitary–ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Bath, Louise E. ; Anderson, Richard A. ; Critchley, Hilary O.D. ; Kelnar, Christopher J.H. ; Wallace, W.Hamish B.</creator><creatorcontrib>Bath, Louise E. ; Anderson, Richard A. ; Critchley, Hilary O.D. ; Kelnar, Christopher J.H. ; Wallace, W.Hamish B.</creatorcontrib><description>BACKGROUND: We assessed adult hypothalamic–pituitary–ovarian function following treatment with chemotherapy and cranial irradiation for childhood acute lymphoblastic leukaemia. METHODS: The patients (n = 12) had median age at diagnosis of 4.7 years, and at assessment of 20.8 years. They collected a daily urine sample over two to five consecutive menstrual cycles (total of 41 cycles) for analysis of LH and steroid excretion. Blood sampling and ovarian ultrasound examination was performed in the early follicular phase. Sixteen healthy women with regular menstrual cycles were recruited as controls. RESULTS: Urinary LH excretion was significantly lower in patients throughout the cycle, particularly during the LH surge (P &lt; 0.0001). The length of the luteal phase was significantly shorter in patients than in normal controls (12.2 ± 0.3 versus 13.6 ± 0.4 days, P = 0.01) with a high prevalence of short (≤11 days) luteal phases (15/39 cycles). Luteal phase pregnanediol excretion was slightly but not significantly lower. Follicular and luteal phase excretion of oestrone was lower in patients than in controls (P = 0.01). Early follicular phase plasma oestradiol was also lower in the patient group (P = 0.032) although LH, FSH, inhibin A and B concentrations were similar. CONCLUSIONS: These data indicate that treatment for childhood leukaemia results in subtle ovulatory disorder in some patients, probably related to cranial irradiation. Follow-up of these women is required to detect any effect on reproductive potential.</description><identifier>ISSN: 0268-1161</identifier><identifier>EISSN: 1460-2350</identifier><identifier>DOI: 10.1093/humrep/16.9.1838</identifier><identifier>PMID: 11527885</identifier><identifier>CODEN: HUREEE</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Acute Disease ; Adult ; Biological and medical sciences ; chemotherapy ; Combined Modality Therapy ; Cranial Irradiation ; Drug toxicity and drugs side effects treatment ; Estradiol - blood ; Estrone - urine ; Female ; Follicular Phase - urine ; Hormones - blood ; Humans ; Hypothalamo-Hypophyseal System - physiopathology ; leukaemia ; Leukemia - drug therapy ; Leukemia - radiotherapy ; Luteal Phase - physiology ; Luteinizing Hormone - urine ; Medical sciences ; Menstrual Cycle - urine ; ovary ; Ovary - physiopathology ; Pharmacology. Drug treatments ; pituitary ; Pregnanediol - urine ; Puberty ; radiotherapy ; Reference Values ; Time Factors ; Toxicity: urogenital system</subject><ispartof>Human reproduction (Oxford), 2001-09, Vol.16 (9), p.1838-1844</ispartof><rights>European Society of Human Reproduction and Embryology 2001</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-20588ecd7f6a882115b4edda2f713a63b89c4566e63eccba7b8a5f6336a14b663</citedby><cites>FETCH-LOGICAL-c441t-20588ecd7f6a882115b4edda2f713a63b89c4566e63eccba7b8a5f6336a14b663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,1585,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14061067$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11527885$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bath, Louise E.</creatorcontrib><creatorcontrib>Anderson, Richard A.</creatorcontrib><creatorcontrib>Critchley, Hilary O.D.</creatorcontrib><creatorcontrib>Kelnar, Christopher J.H.</creatorcontrib><creatorcontrib>Wallace, W.Hamish B.</creatorcontrib><title>Hypothalamic–pituitary–ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia</title><title>Human reproduction (Oxford)</title><addtitle>Hum. Reprod</addtitle><addtitle>Hum. Reprod</addtitle><description>BACKGROUND: We assessed adult hypothalamic–pituitary–ovarian function following treatment with chemotherapy and cranial irradiation for childhood acute lymphoblastic leukaemia. METHODS: The patients (n = 12) had median age at diagnosis of 4.7 years, and at assessment of 20.8 years. They collected a daily urine sample over two to five consecutive menstrual cycles (total of 41 cycles) for analysis of LH and steroid excretion. Blood sampling and ovarian ultrasound examination was performed in the early follicular phase. Sixteen healthy women with regular menstrual cycles were recruited as controls. RESULTS: Urinary LH excretion was significantly lower in patients throughout the cycle, particularly during the LH surge (P &lt; 0.0001). The length of the luteal phase was significantly shorter in patients than in normal controls (12.2 ± 0.3 versus 13.6 ± 0.4 days, P = 0.01) with a high prevalence of short (≤11 days) luteal phases (15/39 cycles). Luteal phase pregnanediol excretion was slightly but not significantly lower. Follicular and luteal phase excretion of oestrone was lower in patients than in controls (P = 0.01). Early follicular phase plasma oestradiol was also lower in the patient group (P = 0.032) although LH, FSH, inhibin A and B concentrations were similar. CONCLUSIONS: These data indicate that treatment for childhood leukaemia results in subtle ovulatory disorder in some patients, probably related to cranial irradiation. Follow-up of these women is required to detect any effect on reproductive potential.</description><subject>Acute Disease</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>chemotherapy</subject><subject>Combined Modality Therapy</subject><subject>Cranial Irradiation</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Estradiol - blood</subject><subject>Estrone - urine</subject><subject>Female</subject><subject>Follicular Phase - urine</subject><subject>Hormones - blood</subject><subject>Humans</subject><subject>Hypothalamo-Hypophyseal System - physiopathology</subject><subject>leukaemia</subject><subject>Leukemia - drug therapy</subject><subject>Leukemia - radiotherapy</subject><subject>Luteal Phase - physiology</subject><subject>Luteinizing Hormone - urine</subject><subject>Medical sciences</subject><subject>Menstrual Cycle - urine</subject><subject>ovary</subject><subject>Ovary - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>pituitary</subject><subject>Pregnanediol - urine</subject><subject>Puberty</subject><subject>radiotherapy</subject><subject>Reference Values</subject><subject>Time Factors</subject><subject>Toxicity: urogenital system</subject><issn>0268-1161</issn><issn>1460-2350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE2LFDEQhoMo7rh69yR90Yv0bNLprs4c3UUdcUAEBdlLqE5XM3H7y3yIffM_-A_9JWbtwb16SkGe963iYeyp4FvBd_LiGAdH84WA7W4rlFT32EaUwPNCVvw-2_ACVC4EiDP2yPuvnKdRwUN2JkRV1EpVG7bsl3kKR-xxsOb3z1-zDdEGdEuap-_oLI5Zu_gujibYacywC-SyOW2NDbmAfWaONKQGcjgvGY5tZhyONn1Y57C1-DfWTS5DEwNlPcUbpMHiY_agw97Tk9N7zj6_ef3pap8fPrx9d_XqkJuyFCEveKUUmbbuAJUq0uVNSW2LRVcLiSAbtTNlBUAgyZgG60Zh1YGUgKJsAOQ5e7H2zm76FskHPVhvqO9xpCl6XQshecWLBPIVNG7y3lGnZ2eHpEILrm9161W3FqB3-lZ3ijw7dcdmoPYucPKbgOcnAL3BvktqjPV3XMlBcKgT93Llpjj_z9p8pa0P9OMfj-5Gp6660vsv1xoOl4frQr7XH-UfXCutAw</recordid><startdate>20010901</startdate><enddate>20010901</enddate><creator>Bath, Louise E.</creator><creator>Anderson, Richard A.</creator><creator>Critchley, Hilary O.D.</creator><creator>Kelnar, Christopher J.H.</creator><creator>Wallace, W.Hamish B.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010901</creationdate><title>Hypothalamic–pituitary–ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia</title><author>Bath, Louise E. ; Anderson, Richard A. ; Critchley, Hilary O.D. ; Kelnar, Christopher J.H. ; Wallace, W.Hamish B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-20588ecd7f6a882115b4edda2f713a63b89c4566e63eccba7b8a5f6336a14b663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acute Disease</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>chemotherapy</topic><topic>Combined Modality Therapy</topic><topic>Cranial Irradiation</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Estradiol - blood</topic><topic>Estrone - urine</topic><topic>Female</topic><topic>Follicular Phase - urine</topic><topic>Hormones - blood</topic><topic>Humans</topic><topic>Hypothalamo-Hypophyseal System - physiopathology</topic><topic>leukaemia</topic><topic>Leukemia - drug therapy</topic><topic>Leukemia - radiotherapy</topic><topic>Luteal Phase - physiology</topic><topic>Luteinizing Hormone - urine</topic><topic>Medical sciences</topic><topic>Menstrual Cycle - urine</topic><topic>ovary</topic><topic>Ovary - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>pituitary</topic><topic>Pregnanediol - urine</topic><topic>Puberty</topic><topic>radiotherapy</topic><topic>Reference Values</topic><topic>Time Factors</topic><topic>Toxicity: urogenital system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bath, Louise E.</creatorcontrib><creatorcontrib>Anderson, Richard A.</creatorcontrib><creatorcontrib>Critchley, Hilary O.D.</creatorcontrib><creatorcontrib>Kelnar, Christopher J.H.</creatorcontrib><creatorcontrib>Wallace, W.Hamish B.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bath, Louise E.</au><au>Anderson, Richard A.</au><au>Critchley, Hilary O.D.</au><au>Kelnar, Christopher J.H.</au><au>Wallace, W.Hamish B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypothalamic–pituitary–ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia</atitle><jtitle>Human reproduction (Oxford)</jtitle><stitle>Hum. Reprod</stitle><addtitle>Hum. Reprod</addtitle><date>2001-09-01</date><risdate>2001</risdate><volume>16</volume><issue>9</issue><spage>1838</spage><epage>1844</epage><pages>1838-1844</pages><issn>0268-1161</issn><eissn>1460-2350</eissn><coden>HUREEE</coden><abstract>BACKGROUND: We assessed adult hypothalamic–pituitary–ovarian function following treatment with chemotherapy and cranial irradiation for childhood acute lymphoblastic leukaemia. METHODS: The patients (n = 12) had median age at diagnosis of 4.7 years, and at assessment of 20.8 years. They collected a daily urine sample over two to five consecutive menstrual cycles (total of 41 cycles) for analysis of LH and steroid excretion. Blood sampling and ovarian ultrasound examination was performed in the early follicular phase. Sixteen healthy women with regular menstrual cycles were recruited as controls. RESULTS: Urinary LH excretion was significantly lower in patients throughout the cycle, particularly during the LH surge (P &lt; 0.0001). The length of the luteal phase was significantly shorter in patients than in normal controls (12.2 ± 0.3 versus 13.6 ± 0.4 days, P = 0.01) with a high prevalence of short (≤11 days) luteal phases (15/39 cycles). Luteal phase pregnanediol excretion was slightly but not significantly lower. Follicular and luteal phase excretion of oestrone was lower in patients than in controls (P = 0.01). Early follicular phase plasma oestradiol was also lower in the patient group (P = 0.032) although LH, FSH, inhibin A and B concentrations were similar. CONCLUSIONS: These data indicate that treatment for childhood leukaemia results in subtle ovulatory disorder in some patients, probably related to cranial irradiation. Follow-up of these women is required to detect any effect on reproductive potential.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>11527885</pmid><doi>10.1093/humrep/16.9.1838</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-1161
ispartof Human reproduction (Oxford), 2001-09, Vol.16 (9), p.1838-1844
issn 0268-1161
1460-2350
language eng
recordid cdi_proquest_miscellaneous_71130502
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current)
subjects Acute Disease
Adult
Biological and medical sciences
chemotherapy
Combined Modality Therapy
Cranial Irradiation
Drug toxicity and drugs side effects treatment
Estradiol - blood
Estrone - urine
Female
Follicular Phase - urine
Hormones - blood
Humans
Hypothalamo-Hypophyseal System - physiopathology
leukaemia
Leukemia - drug therapy
Leukemia - radiotherapy
Luteal Phase - physiology
Luteinizing Hormone - urine
Medical sciences
Menstrual Cycle - urine
ovary
Ovary - physiopathology
Pharmacology. Drug treatments
pituitary
Pregnanediol - urine
Puberty
radiotherapy
Reference Values
Time Factors
Toxicity: urogenital system
title Hypothalamic–pituitary–ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T07%3A35%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypothalamic%E2%80%93pituitary%E2%80%93ovarian%20dysfunction%20after%20prepubertal%20chemotherapy%20and%20cranial%20irradiation%20for%20acute%20leukaemia&rft.jtitle=Human%20reproduction%20(Oxford)&rft.au=Bath,%20Louise%20E.&rft.date=2001-09-01&rft.volume=16&rft.issue=9&rft.spage=1838&rft.epage=1844&rft.pages=1838-1844&rft.issn=0268-1161&rft.eissn=1460-2350&rft.coden=HUREEE&rft_id=info:doi/10.1093/humrep/16.9.1838&rft_dat=%3Cproquest_cross%3E71130502%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71130502&rft_id=info:pmid/11527885&rft_oup_id=10.1093/humrep/16.9.1838&rfr_iscdi=true